|
||||||||||||||||||||||||
Table IV. Average FDA review time and average total elapsed time, from filing to clearance, for all premarket notifications (510(k)s) receiving substantially equivalent or not substantially equivalent decisions, FY01–FY05. Source: FDA Office of Device Evaluation. |
||||||||||||||||||||||||